Epidemiology and subtypes of lymphoid neoplasms

Authors

Keywords:

lymphoid neoplasms, epidemiology, subtypes

Abstract

Introduction: Hodgkin and non-Hodgkin lymphomas are malignant neoplasms derived from cellular components of the immune system, in particular, lymphocytes and their precursors, and constitute a very heterogeneous group, with wide clinicobiological, prognostic and therapeutic differences. Objective: to characterize the patients treated in the Multidisciplinary Lymphomas Consultation of the Celestino Hernández Robau Hospital. Method: a descriptive and cross-sectional investigation was conducted in adult patients of Villa Clara province, during a period from January 1rst, 2014 to December 31st, 2015. Results: a total of 81 cases were evaluated, with a predominance of ages older and equal to 60 years, male and white skin color, as personal pathological history, patients with arterial hypertension predominated, Non-Hodgkin lymphoma was more frequent than Hodgkin lymphoma, within the histological varieties of Hodgkin's Lymphoma nodular sclerosis appears, while for non-Hodgkin's Lymphomas the large cells diffuse occupies the first place, the stage with the highest number of patients is IIA and IIIB for both types of lymphomas (this is associated with the greatest number of patients presented symptoms B), the elapsed time from the onset of symptoms until the diagnosis was greater than three months, and complete remission to treatment predominated in both pathologies. Conclusions: Lymphomas have a high morbidity in adults of Villa Clara province.

Downloads

Download data is not yet available.

Author Biographies

Leydis Aguilera Hernández, Hospital Universitario "Celestino Hernandez Robau"

Especialista de I Grado en Oncología Clínica

Olga Lidia Alonso Mariño, Hospital Universitario "Celestino Hernandez Robau"

Especialista de II Grado en Hematología. Máster en Enfermedades Infecciosas. Máster en Bioética. Profesora Auxiliar e Investigadora agregada de la Universidad de Ciencias Médicas de Villa Clara.

Ana Luisa Alonso Mariño, Hospital Universitario "Celestino Hernandez Robau"

Especialista de II Grado en Medicina Intensiva y Emergencias. Máster en Urgencias Médicas. Máster en Enfermedades Infecciosas. Máster en Bioética. Profesora Auxiliar e Investigadora agregada de la Universidad de Ciencias Médicas de Villa Clara.

References

1. Swerdlow S, Campo L, Pileri S, Harris N, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood [Internet]. 2016 May [citado 11 Sep 2017];127(20):2375-90. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26980727

2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer [Internet]. 2015 Mar [citado 11 Sep 2017];136(5):E359-E386. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25220842

3. Cuba. Ministerio de Salud Pública. Anuario estadístico de Salud 2015. [Internet]. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2016 [citado 11 Sep 2017]. Disponible en: http://files.sld.cu/dne/files/2016/04/Anuario_2015_electronico-1.pdf

4. Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol [Internet]. 1989 Nov [citado 22 May 2014];7(11):1630-6. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/2809679

5. Freedman AS, Jacobson CA, Mauch P, Aster JC. Non-Hodgkin lymphoma. In: De Vita VT.Cancer Principles & Practice of Oncology.10ma ed. Philadelphia: Wolters Kluwer; 2015. p. 1552-83.

6. Ron-Guerrero CS, Ron-Magaña AL, Medina-Palacios CL, López-Flores F. Epidemiología de los linfomas del Centro Estatal de Cancerología de Nayarit. Rev Hematol Mex [Internet]. 2015 [citado 11 Sep 2017];16(2):109-14. Disponible en: http://www.medigraphic.com/pdfs/hematologia/re-2015/re152b.pdf

7. Campos Ortiz AB, Capelo Burgos TP, Carmona Ortiz MP. Factores de riesgo y de pronóstico de linfoma no Hodgkin de células B, en pacientes mayores de 15 años, instituto del cáncer, Solca-Cuenca [tesis]. Ecuador: Universidad de Cuenca; 2013. Disponible en: http://dspace.ucuenca.edu.ec/bitstream/123456789/3242/1/MED161.pdf

8. Gómez Gómez MJ. Aportación al conocimiento clínico y pronóstico de los linfomas de cabeza y cuello [tesis]. España: Universidad de Valencia. Facultad de Medicina y Odontología; 2015. Disponible en: http://roderic.uv.es/bitstream/handle/10550/50909/Tesis%20MJos%C3%A9%20G%C3%B3mez%20definitiva.pdf?sequence=1&isAllowed=y

9. Mejía Freire SA, Molina Calderón AA. Características, clínicas, demográficas e histopatológicas de pacientes con linfomas no Hodgkin [tesis]. Ecuador: Universidad del Azuay; 2015. Disponible en: http://dspace.uazuay.edu.ec/bitstream/datos/5006/1/11444.pdf

10. Alonso Mariño OL, Alonso Mariño AL, Miranda Chaviano J. Caracterización clínico-epidemiológica de los linfomas en un período de cinco años en Villa Clara. Medicent Electrón [Internet]. 2015 Ene-Mar [citado 11 Sep 2017];19(1):13-20. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30432015000100003

11. Sánchez Fernández J, Cabrera Menéndez A, Pérez Pi A, Merino Concepción J. Estudio de las principales causas de muerte en Guanajay en el año 2013. MediSur [Internet]. 2015 May-Jun [citado 11 Sep 2017];13(3):383-90. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2015000300008

12. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol [Internet]. 1999 Dec [citado 22 May 2014];17(12):3835-49. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/10577857

13. Sarmiento-Chavero M, Gabiño-López NB. Entendiendo el inmunofenotipo de las neoplasias de células B maduras. Rev Invest Med Sur Mex [Internet]. 2012 [citado 22 May 2014];19(4):212-21. Disponible en: http://www.medigraphic.com/pdfs/medsur/ms-2012/ms124d.pdf

14. Baksh N, Maghfoor I. The current lymphoma classification: new concepts and practical applications triumphs and woes. Ann Saudi Med [Internet]. 2012 [citado 22 May 2014];32(3):296-305. Disponible en: http://www.annsaudimed.net/index.php/vol32/vol32iss3/20.html

15. Cruz-Contreras D, Reyes-Pérez EN, Limón-Flores A, Mendoza-García A, Gutiérrez-Quiroz C, Pérez-Corro M, et al. Frecuencia y variedades de linfomas en un hospital de concentración público mexicano de tercer nivel. Rev Hematol Mex [Internet]. 2015 Ene-Mar [citado 11 Sep 2017];16:9-16. Disponible en: http://www.medigraphic.com/pdfs/hematologia/re-2015/re151c.pdf

Downloads

Published

2018-07-02

How to Cite

1.
Aguilera Hernández L, Alonso Mariño OL, Alonso Mariño AL. Epidemiology and subtypes of lymphoid neoplasms. Acta Méd Centro [Internet]. 2018 Jul. 2 [cited 2025 Jun. 28];12(3):286-92. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/897

Issue

Vol. 12 No. 3 (2018): July-September

Section

Original Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).